Methylation estimates the risk of precancer in HPV-infected women with discrepant results between cytology and HPV16/18 genotyping

BACKGROUND: Vigilant management of women with high-risk human papillomavirus (hrHPV) is necessary in cancer screening programs. To this end, we evaluated the performance of S5 (targeting DNA methylation in HPV16, HPV18, HPV31, HPV33, and human gene EPB41L3) to predict cervical intraepithelial neopla...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernández-López, Rubí, Lorincz, Attila T., Torres-Ibarra, Leticia, Reuter, Caroline, Scibior-Bentkowska, Dorota, Warman, Rhian, Nedjai, Belinda, Mendiola-Pastrana, Indira, León-Maldonado, Leith, Rivera-Paredez, Berenice, Ramírez-Palacios, Paula, Lazcano-Ponce, Eduardo, Cuzick, Jack, Salmerón, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790057/
https://www.ncbi.nlm.nih.gov/pubmed/31606044
http://dx.doi.org/10.1186/s13148-019-0743-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790057/
https://www.ncbi.nlm.nih.gov/pubmed/31606044
http://dx.doi.org/10.1186/s13148-019-0743-9

Ejemplares similares